Comparison of the effect of intravitreal bevacizumab and intravitreal fasudil on retinal VEGF, TNFα, and caspase 3 levels in an experimental diabetes model

<b>AIM:</b> To evaluate the influence of an intravitreal injection of bevacizumab and fasudil on the retinal vascular endothelial growth factor (VEGF), tumor necrosis factor alpha (TNFα), and caspase 3 levels in a diabetic rabbit model.<b>RESULTS:</b> There was a statisticall...

Full description

Bibliographic Details
Main Authors: Fatih Çelik, Fatih Ulaş, Zeynep Güneş Özünal, Tülin Fırat, Serdal Çelebi, Ümit Doğan
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2014-02-01
Series:International Journal of Ophthalmology
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949459/
_version_ 1819016677246894080
author Fatih Çelik
Fatih Ulaş
Zeynep Güneş Özünal
Tülin Fırat
Serdal Çelebi
Ümit Doğan
author_facet Fatih Çelik
Fatih Ulaş
Zeynep Güneş Özünal
Tülin Fırat
Serdal Çelebi
Ümit Doğan
author_sort Fatih Çelik
collection DOAJ
description <b>AIM:</b> To evaluate the influence of an intravitreal injection of bevacizumab and fasudil on the retinal vascular endothelial growth factor (VEGF), tumor necrosis factor alpha (TNFα), and caspase 3 levels in a diabetic rabbit model.<b>RESULTS:</b> There was a statistically significant difference in the VEGF and caspase 3 levels between groups (<i>P</i>=0.005 and <i>P</i> =0.013, respectively), but the TNFα level did not differ significantly between groups (<i>P</i>=0.792). It was found that VEGF levels were significantly lower in Group 1 and Group 3 than in Group 2 using the Mann-Whitney <i>U</i> test with the Bonferroni correction (<i>P</i>=0.004 for both comparison). There was no statistically significant difference between other groups with regard to VEGF levels (the <i>P</i> value ranged between 0.015 and 0.886). Although the <i>P</i> values of the caspase 3 levels were 0.015 for Group 1 and Group 4, 0.038 for Group 2 and Group 3, and 0.018 for Group 3 and Group 4, these <i>P</i> values remained above the threshold <i>P</i> value of 0.0083, which was the statistically significant level for post hoc tests.<b>CONCLUSION:</b> An intravitreal injection of bevacizumab decreased both the VEGF level, which plays a role in angiogenesis, and the caspase 3 level, which plays a role in apoptosis. Although not as effective as bevacizumab, fasudil had a beneficial effect on the VEGF levels but significantly increased the caspase 3 levels.
first_indexed 2024-12-21T02:51:26Z
format Article
id doaj.art-729ad5673ef14e6689b54f0939373c7c
institution Directory Open Access Journal
issn 2222-3959
2227-4898
language English
last_indexed 2024-12-21T02:51:26Z
publishDate 2014-02-01
publisher Press of International Journal of Ophthalmology (IJO PRESS)
record_format Article
series International Journal of Ophthalmology
spelling doaj.art-729ad5673ef14e6689b54f0939373c7c2022-12-21T19:18:25ZengPress of International Journal of Ophthalmology (IJO PRESS)International Journal of Ophthalmology2222-39592227-48982014-02-0171576110.3980/j.issn.2222-3959.2014.01.10Comparison of the effect of intravitreal bevacizumab and intravitreal fasudil on retinal VEGF, TNFα, and caspase 3 levels in an experimental diabetes modelFatih Çelik0Fatih Ulaş1Zeynep Güneş Özünal2Tülin Fırat3Serdal Çelebi4Ümit Doğan5Department of Ophthalmology, Faculty of Medicine, Abant Izzet Baysal University, Bolu 14280, Turkey<br>Department of Ophthalmology, Faculty of Medicine, Abant Izzet Baysal University, Bolu 14280, Turkey<br>Department of Medical Pharmacology, Faculty of Medicine, Abant Izzet Baysal University, Bolu 14280, Turkey<br>Department of Histology and Embryology, Faculty of Medicine, Abant Izzet Baysal University, Bolu 14280, TurkeyDepartment of Ophthalmology, Faculty of Medicine, Abant Izzet Baysal University, Bolu 14280, Turkey<br>Department of Ophthalmology, Faculty of Medicine, Abant Izzet Baysal University, Bolu 14280, Turkey<br><b>AIM:</b> To evaluate the influence of an intravitreal injection of bevacizumab and fasudil on the retinal vascular endothelial growth factor (VEGF), tumor necrosis factor alpha (TNFα), and caspase 3 levels in a diabetic rabbit model.<b>RESULTS:</b> There was a statistically significant difference in the VEGF and caspase 3 levels between groups (<i>P</i>=0.005 and <i>P</i> =0.013, respectively), but the TNFα level did not differ significantly between groups (<i>P</i>=0.792). It was found that VEGF levels were significantly lower in Group 1 and Group 3 than in Group 2 using the Mann-Whitney <i>U</i> test with the Bonferroni correction (<i>P</i>=0.004 for both comparison). There was no statistically significant difference between other groups with regard to VEGF levels (the <i>P</i> value ranged between 0.015 and 0.886). Although the <i>P</i> values of the caspase 3 levels were 0.015 for Group 1 and Group 4, 0.038 for Group 2 and Group 3, and 0.018 for Group 3 and Group 4, these <i>P</i> values remained above the threshold <i>P</i> value of 0.0083, which was the statistically significant level for post hoc tests.<b>CONCLUSION:</b> An intravitreal injection of bevacizumab decreased both the VEGF level, which plays a role in angiogenesis, and the caspase 3 level, which plays a role in apoptosis. Although not as effective as bevacizumab, fasudil had a beneficial effect on the VEGF levels but significantly increased the caspase 3 levels.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949459/bevacizumabcaspase 3experimental diabetesfasudiltumor necrosis factor alphavascular endothelial growth factorvascular endothelial growth factor
spellingShingle Fatih Çelik
Fatih Ulaş
Zeynep Güneş Özünal
Tülin Fırat
Serdal Çelebi
Ümit Doğan
Comparison of the effect of intravitreal bevacizumab and intravitreal fasudil on retinal VEGF, TNFα, and caspase 3 levels in an experimental diabetes model
International Journal of Ophthalmology
bevacizumab
caspase 3
experimental diabetes
fasudil
tumor necrosis factor alpha
vascular endothelial growth factor
vascular endothelial growth factor
title Comparison of the effect of intravitreal bevacizumab and intravitreal fasudil on retinal VEGF, TNFα, and caspase 3 levels in an experimental diabetes model
title_full Comparison of the effect of intravitreal bevacizumab and intravitreal fasudil on retinal VEGF, TNFα, and caspase 3 levels in an experimental diabetes model
title_fullStr Comparison of the effect of intravitreal bevacizumab and intravitreal fasudil on retinal VEGF, TNFα, and caspase 3 levels in an experimental diabetes model
title_full_unstemmed Comparison of the effect of intravitreal bevacizumab and intravitreal fasudil on retinal VEGF, TNFα, and caspase 3 levels in an experimental diabetes model
title_short Comparison of the effect of intravitreal bevacizumab and intravitreal fasudil on retinal VEGF, TNFα, and caspase 3 levels in an experimental diabetes model
title_sort comparison of the effect of intravitreal bevacizumab and intravitreal fasudil on retinal vegf tnfα and caspase 3 levels in an experimental diabetes model
topic bevacizumab
caspase 3
experimental diabetes
fasudil
tumor necrosis factor alpha
vascular endothelial growth factor
vascular endothelial growth factor
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949459/
work_keys_str_mv AT fatihcelik comparisonoftheeffectofintravitrealbevacizumabandintravitrealfasudilonretinalvegftnfaandcaspase3levelsinanexperimentaldiabetesmodel
AT fatihulas comparisonoftheeffectofintravitrealbevacizumabandintravitrealfasudilonretinalvegftnfaandcaspase3levelsinanexperimentaldiabetesmodel
AT zeynepgunesozunal comparisonoftheeffectofintravitrealbevacizumabandintravitrealfasudilonretinalvegftnfaandcaspase3levelsinanexperimentaldiabetesmodel
AT tulinfırat comparisonoftheeffectofintravitrealbevacizumabandintravitrealfasudilonretinalvegftnfaandcaspase3levelsinanexperimentaldiabetesmodel
AT serdalcelebi comparisonoftheeffectofintravitrealbevacizumabandintravitrealfasudilonretinalvegftnfaandcaspase3levelsinanexperimentaldiabetesmodel
AT umitdogan comparisonoftheeffectofintravitrealbevacizumabandintravitrealfasudilonretinalvegftnfaandcaspase3levelsinanexperimentaldiabetesmodel